3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
58
Carcinoma, Non-Small-Cell Lung
36
Urinary Bladder Neoplasms
33
Neoplasm Metastasis
20
Lung Neoplasms
20
Ovarian Neoplasms
19
Lymphoma, Large B-Cell, Diffuse
18
Cholangiocarcinoma
15
Neoplasms
14
Nasopharyngeal Carcinoma
14
Biliary Tract Neoplasms
14
Triple Negative Breast Neoplasms
13
Colorectal Neoplasms
12
Breast Neoplasms
12
Carcinoma, Transitional Cell
11
Non-Muscle Invasive Bladder Neoplasms
10
Fallopian Tube Neoplasms
10
Recurrence
9
Gallbladder Neoplasms
8
Sarcoma
6
Parkinson Disease 4, Autosomal Dominant Lewy Body
6
Bile Duct Neoplasms
6
Uterine Cervical Neoplasms
5
Osteosarcoma
5
Lymphoma, Non-Hodgkin
5
Lymphoma
5
Hodgkin Disease
5
Endometrial Neoplasms
5
Melanoma
4
Gastrointestinal Neoplasms
4
Interventions
Imatinib Mesylate
6
Sunitinib
4
ripretinib
2
regorafenib
2
Specimen Handling
2
Paclitaxel
2
Magnetic Resonance Spectroscopy
2
IDRX-42
2
trastuzumab deruxtecan
1
pemigatinib
1
olverembatinib
1
envafolimab
1
atezolizumab
1
apatinib
1
Temozolomide
1
Surgical Instruments
1
Sorafenib
1
Rogaratinib
1
Nivolumab
1
Midazolam
1
Laparoscopy
1
Ipilimumab
1
Cyclophosphamide
1
CTLA-4 Antigen
1
Blood Specimen Collection
1
Biopsy
1
4-Aminopyridine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastrointestinal Stromal Tumors
×
Gemcitabine
×
90 days
×
Clear all
No trials found.